Molecular regulations induced by acrolein in neuroblastoma SK-N-SH cells: Relevance to Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 21, Issue 4, 2010, Pages 1197-1216

  Thanh Nam, Dang ^a   Arseneault, Madeleine ^a   Zarkovic, Neven ^b   Waeg, Georg ^c   Ramassamy, Charles ^a,d  

^a INRS INSTITUT ARMAND FRAPPIER   (Canada)

^b RUDER BO KOVI INSTITUTE   (Croatia)

^c UNIVERSITY OF GRAZ   (Austria)

^d UNIVERSITÉ LAVAL   (Canada)

Author keywords

Acrolein; Alzheimer disease; lipid peroxidation; oxidative stress

Indexed keywords

ACROLEIN; CASPASE 3; GLUTATHIONE TRANSFERASE; HEME OXYGENASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SIRTUIN 1; TRANSCRIPTION FACTOR NRF2;

ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DNA FRAGMENTATION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; NEUROBLASTOMA; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CARBONYLATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 78650439462     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-100417     Document Type: Article

References (87)

1. Christen Y (2000) Oxidative stress and Alzheimer disease. Am J Clin Nutr 71, 621S-629S.
2. Sonnen JA, Breitner JC, Lovell MA, Markesbery WR, Quinn JF, Montine TJ (2008) Free radical-mediated damage to brain in Alzheimer's disease and its transgenic mouse models. Free Radic Biol Med 45, 219-230.
3. Reynolds A, Laurie C, Mosley RL, Gendelman HE (2007) Oxidative stress and the pathogenesis of neurodegenerative disorders. Int Rev Neurobiol 82, 297-325.
4. Shibata N, Kobayashi M (2008) [The role for oxidative stress in acetate:ethanol (1:1) by centrifugation at 16000xg for 10 min. neurodegenerative diseases]. Brain Nerve 60, 157170.
5. Uttara B, Singh AV, Zamboni P, Mahajan RT (2009) Oxida-tive stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol 7, 65-74.
6. Tsang AH, Chung KK (2009) Oxidative and nitrosative stress in Parkinson's disease. Biochim Biophys Acta 1792, 643-650.
7. Zarkovic K (2003) 4-hydroxynonenal and neurodegenerative diseases. Mol Aspects Med 24, 293-303.
8. Casadesus G, Smith MA, Basu S, Hua J, Capobianco DE, Siedlak SL, Zhu X, Perry G (2007) Increased isoprostane and prostaglandin are prominent in neurons in Alzheimer disease. Mol Neurodegener 2, 2.
9. Reed TT, Pierce WM, Markesbery WR, Butterfield DA (2009) Proteomic identification of HNE-bound proteins in early Alzheimer disease: Insights into the role of lipid peroxidation in the progression of AD. Brain Res 1274, 66-76.
10. Sultana N (2009) Proteomics identification of carbonylated and HNE-bound brain proteins in Alzheimer's disease. Methods MolBiol 566, 123-135.
11. Calingasan NY, Uchida K, Gibson GE (1999) Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer's disease. J Neurochem 72, 751-756.
12. Sayre LM, Zelasko DA, Harris PL, Perry G, Salomon RG, Smith MA (1997) 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. JNeurochem 68, 2092-2097.
13. Montine KS, Olson SJ, Amarnath V, Whetsell WO, Jr., Graham DG, Montine TJ (1997) Immunohistochemical detection of 4-hydroxy-2-nonenal adducts in Alzheimer's disease is associated with inheritance of APOE4. Am J Pathol 150, 437443.
14. Ramassamy C, Averill D, Beffert U, Bastianetto S, Theroux L, Lussier-Cacan S, Cohn JS, Christen Y, Davignon J, Quirion R, Poirier J (1999) Oxidative damage and protection by antiox-idants in the frontal cortex of Alzheimer's disease is related to the apolipoprotein E genotype. Free Radic Biol Med 27, 544-553.
15. Ramassamy C, AverillD, BeffertU, TherouxL, Lussier-Cacan S, Cohn JS, Christen Y, Schoofs A, Davignon J, Poirier J (2000) Oxidative insults are associated with apolipoprotein E genotype in Alzheimer's disease brain. Neurobiol Dis 7, 23-37.
16. EsterbauerH, Schaur RJ, Zollner H (1991) Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 11, 81-128.
17. Bradley MA, Markesbery WR, Lovell MA (2010) Increased levels of 4-hydroxynonenal and acrolein in the brain in pre-clinical Alzheimer's disease (PCAD). Free Radic Biol Med 48, 1570-1576.
18. Williams TI, Lynn BC, Markesbery WR, Lovell MA (2006) Increased levels of4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in mild Cognitive Impairment and early Alzheimer's disease. Neurobiol Aging 27, 1094-1099.
19. Lovell MA, Xie C, Markesbery WR (2001) Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures. Neurobiol Aging 22, 187-194.
20. Markesbery WR, Lovell MA (1998) Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease. Neurobiol Aging 19, 33-36.
21. Liu X, Lovell MA, Lynn BC (2005) Development of amethod for quantification ofacrolein-deoxyguanosine adducts in DNA using isotope dilution-capillary LC/MS/MS and its application to human brain tissue. Anal Chem 77, 5982-5989.
22. Liu X, Lovell MA, Lynn BC (2006) Detection and quantification of endogenous cyclic DNA adducts derived from trans-4-hydroxy-2-nonenal in human brain tissue by isotope dilution capillary liquid chromatography nanoelectrospray tandem mass spectrometry. Chem Res Toxicol 19, 710-718.
23. Kozekov ID, Nechev LV, Moseley MS, Harris CM, Rizzo CJ, Stone MP, Harris TM (2003) DNA interchain cross-links formed by acrolein and crotonaldehyde. J Am Chem Soc 125, 50-61.
24. Bernstein HG, Muller M (1999) The cellular localization ofthe L-ornithine decarboxylase/polyamine system in normal and diseased central nervous systems. Prog Neurobiol 57, 485505.
25. Bernstein HG, Muller M (1995) Increased immunostaining for L-ornithine decarboxylase occurs in neocortical neurons of Alzheimer's disease patients. Neurosci Lett 186, 123-126.
26. Hinson JA, Roberts DW (1992) Role of covalent and nonco-valent interactions in cell toxicity: effects on proteins. Annu Rev Pharmacol Toxicol 32, 471-510.
27. Lovell MA, Xie C, Markesbery WR (2000) Acrolein, a product of lipid peroxidation, inhibits glucose and glutamate uptake in primary neuronal cultures. Free Radic Biol Med 29, 714-720.
28. Luo J, Robinson JP, Shi R (2005) Acrolein-induced cell death in PC12 cells: role of mitochondria-mediated oxidative stress. Neurochem Int 47, 449-457.
29. Mello CF, Sultana R, Piroddi M, Cai J, Pierce WM, Klein JB, Butterfield DA (2007) Acrolein induces selective protein carbonylation in synaptosomes. Neuroscience 147, 674-679.
30. Pocernich CB, Butterfield DA (2003) Acrolein inhibits NADH-linked mitochondrial enzyme activity: implications for Alzheimer's disease. Neurotox Res 5, 515-520.
31. Liu-Snyder P, Borgens RB, Shi R (2006) Hydralazine rescues PC12 cells from acrolein-mediated death. J Neurosci Res 84, 219-227.
32. Ba F, Pang PK, Benishin CG (2003) The establishment of a reliable cytotoxic system with SK-N-SH neuroblastoma cell culture. J Neurosci Methods 123, 11-22.
33. RoehmNW, Rodgers GH, Hatfield SM, Glasebrook AL(1991) An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT. J Immunol Methods 142, 257-265.
34. Kamencic H, Lyon A, Paterson PG, Juurlink BH (2000) Monochlorobimane fluorometric method to measure tissue glutathione. Anal Biochem 286, 35-37.
35. Habig WH, Pabst MJ, Fleischner G, Gatmaitan Z, Arias IM, Jakoby WB (1974) The identity of glutathione S-transferase B with ligandin, a major binding protein of liver. Proc Natl AcadSci USA 71, 3879-3882.
36. Waeg G, Dimsity G, Esterbauer H (1996) Monoclonal antibodies for detection of 4-hydroxynonenal modified proteins. Free Radic Res 25, 149-159.
37. Sovic A, Borovic S, Loncaric I, Kreuzer T, Zarkovic K, Vukovic T, Wag G, Hrascan R, Wintersteiger R, Klinger R, ZurakN, Schaub RJ, Zarkovic N (2001) The carcinostatic and proapoptotic potential of 4-hydroxynonenal in HeLa cells is associated with its conjugation to cellular proteins. Anticancer Res 21, 1997-2004.
38. Borovic S, Rabuzin F, Waeg G, Zarkovic N (2006) Enzyme-linked immunosorbent assay for 4-hydroxynonenal-histidine conjugates. Free Radic Res 40, 809-820.
39. Pugazhenthi S, Phansalkar K, Audesirk G, West A, Cabell L (2006) Differential regulation of c-jun and CREB by acrolein and 4-hydroxynonenal. Free Radic Biol Med 40, 21-34.
40. Tanel A, Averill-Bates DA (2005) The aldehyde acrolein induces apoptosis via activation of the mitochondrial pathway. Biochim Biophys Acta 1743, 255-267.
41. Liu-Snyder P, McNally H, Shi R, Borgens RB (2006) Acrolein-mediated mechanisms of neuronal death. J Neurosci Res 84, 209-218.
42. Pocernich CB, Cardin AL, Racine CL, Lauderback CM, But-terfield DA (2001) Glutathione elevation and its protective role in acrolein-induced protein damage in synaptosomal membranes: relevance to brain lipid peroxidation in neurodegener-ative disease. Neurochem Int 39, 141-149.
43. Hu Y, Wang X, Zeng L, Cai DY, Sabapathy K, Goff SP, Fir-po EJ, Li B (2005) ERK phosphorylates p66shcA on Ser36 and subsequently regulates p27kip 1 expression via the Akt-FOXO3a pathway: implication of p27kip1 in cell response to oxidative stress. MolBiol Cell 16, 3705-3718.
44. Migliaccio E, Giorgio M, Mele S, Pelicci G, Reboldi P, Pan-dolfi PP, Lanfrancone L, Pelicci PG (1999) The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature 402, 309-313.
45. Wu Z, Rogers B, Kachi S, Hackett SF, Sick A, Campochiaro PA (2006) Reduction of p66Shc suppresses oxidative damage in retinal pigmented epithelial cells and retina. J Cell Physiol 209, 996-1005.
46. Uchida K (1999) Current status of acrolein as a lipid peroxi-dation product. Trends Cardiovasc Med 9, 109-113.
47. Cai J, Bhatnagar A, Pierce WM, Jr. (2009) Protein modification by acrolein: formation and stability of cysteine adducts. Chem Res Toxicol 22, 708-716.
48. LoPachin RM, Barber DS, Gavin T (2008) Molecular mechanisms of the conjugated alpha,beta-unsaturated carbonyl derivatives: relevance to neurotoxicity and neurodegenerative diseases. Toxicol Sci 104, 235-249.
49. Satoh K, Yamada S, Koike Y, Igarashi Y, Toyokuni S, Kumano T, Takahata T, Hayakari M, Tsuchida S, Uchida K (1999) A 1hour enzyme-linked immunosorbent assay for quantitation of acrolein-and hydroxynonenal-modified proteins by epitope-bound casein matrix method. Anal Biochem 270, 323-328.
50. Nardini M, Finkelstein EI, Reddy S, Valacchi G, Traber M, Cross CE, van der Vliet A (2002) Acrolein-induced cytotoxic-ity in cultured human bronchial epithelial cells. Modulation by alpha-tocopherol and ascorbic acid. Toxicology 170, 173-185.
51. Picklo MJ, Montine TJ (2001) Acrolein inhibits respiration in isolated brain mitochondria. Biochim Biophys Acta 1535, 145-152.
52. Jia Z, Misra BR, Zhu H, Li Y, Misra HP (2009) Upregulation of cellular glutathione by 3H-1,2-dithiole-3-thione as apossi-ble treatment strategy for protecting against acrolein-induced neurocytotoxicity. Neurotoxicology 30, 1-9.
53. Lovell MA, Xie C, Markesbery WR (1998) Decreased glu-tathione transferase activity in brain and ventricular fluid in Alzheimer's disease. Neurology 51, 1562-1566.
54. Adams JD, Jr., Klaidman LK (1993) Acrolein-induced oxygen radical formation. Free Radic Biol Med 15, 187-193.
55. Mitchell DY, Petersen DR (1989) Metabolism of the glutathione-acrolein adduct, S-(2-aldehydo-ethyl)glutathione, by rat liver alcohol and aldehyde dehydrogenase. J Pharmacol ExpTher 251, 193-198.
56. Picklo MJ, Olson SJ, Markesbery WR, Montine TJ (2001) Expression and activities of aldo-keto oxidoreductases in Alzheimer disease. JNeuropathol Exp Neurol 60, 686-695.
57. Kamino K, Nagasaka K, Imagawa M, Yamamoto H, Yoneda H, Ueki A, Kitamura S, Namekata K, Miki T, Ohta S (2000) Deficiency in mitochondrial aldehyde dehydrogenase increases the risk for late-onset Alzheimer's disease in the Japanese population. Biochem Biophys Res Commun 273, 192-196.
58. Wang X, Sheikh S, Saigal D, Robinson L, Weiner H (1996) Heterotetramers of human liver mitochondrial (class 2) aldehyde dehydrogenase expressed in Escherichia coli. A model to study the heterotetramers expected to be found in Oriental people. J Biol Chem 271, 31172-31178.
59. Ohta S, Ohsawa I (2006) Dysfunction of mitochondria and oxidative stress in the pathogenesis of Alzheimer's disease: on defects in the cytochrome c oxidase complex and aldehyde detoxification. J Alzheimers Dis 9, 155-166.
60. Jaeschke H, Kleinwaechter C, Wendel A (1987) The role of acrolein in allyl alcohol-induced lipid peroxidation and liver cell damage in mice. Biochem Pharmacol 36, 51-57.
61. Uchida K, Shiraishi M, Naito Y, Torii Y, Nakamura Y, Osawa T (1999) Activation of stress signaling pathways by the end product of lipid peroxidation. 4-hydroxy-2-nonenal is a potential inducer of intracellular peroxide production. J Biol Chem 274, 2234-2242.
62. Shamoto-Nagai M, Maruyama W, Hashizume Y, Yoshida M, Osawa T, Riederer P, Naoi M (2007) In parkinsonian sub-stantia nigra, alpha-synuclein is modified by acrolein, a lipid-peroxidation product, and accumulates in the dopamine neurons with inhibition of proteasome activity. J Neural Transm 114, 1559-1567.
63. Uchida K, Kanematsu M, Sakai K, Matsuda T, Hattori N, Mizuno Y, Suzuki D, Miyata T, Noguchi N, Niki E, Osawa T (1998) Protein-bound acrolein: potential markers for oxidative stress. Proc Natl Acad Sci USA 95, 4882-4887.
64. Galloway PG, Mulvihill P, Siedlak S, Mijares M, Kawai M, Padget H, Kim R, Perry G (1990) Immunochemical demonstration of tropomyosin in the neurofibrillary pathology of Alzheimer's disease. Am J Pathol 137, 291-300.
65. Perez-Gracia E, Blanco R, Carmona M, Carro E, Ferrer I (2009) Oxidative stress damage and oxidative stress responses in the choroidplexus in Alzheimer's disease. ActaNeuropathol 118, 497-504.
66. Roy J, Pallepati P, Bettaieb A, Tanel A, Averill-Bates DA (2009) Acrolein induces a cellular stress response and triggers mitochondrial apoptosis in A549 cells. Chem Biol Interact 181, 154-167.
67. Tanel A, Averill-Bates DA (2007) P38 and ERK mitogen-activated protein kinases mediate acrolein-induced apoptosis in Chinese hamster ovary cells. Cell Signal 19, 968-977.
68. Tanel A, Averill-Bates DA (2007) Activation of the death receptor pathway of apoptosis by the aldehyde acrolein. Free Radic Biol Med 42, 798-810.
69. Lambert C, Li J, Jonscher K, Yang TC, Reigan P, Quintana M, Harvey J, Freed BM (2007) Acrolein inhibits cytokine gene expression by alkylating cysteine and arginine residues in the NF-kappaB1 DNA binding domain. J Biol Chem 282, 19666-19675.
70. Haberzettl P, Vladykovskaya E, Srivastava S, Bhatnagar A (2009) Role of endoplasmic reticulum stress in acrolein-induced endothelial activation. Toxicol Appl Pharmacol 234, 14-24.
71. Yang H, Wang J, Huang ZZ, Ou X, Lu SC (2001) Cloning and characterization of the 5'-flanking region of the rat glutamate-cysteine ligase catalytic subunit. Biochem J 357, 447-455. (Pubitemid 32701781)
72. Wild AC, Moinova HR, Mulcahy RT (1999) Regulation of gamma- glutamylcysteine synthetase subunit gene expression by the transcription factor Nrf2. J Biol Chem 274, 3362733636.
73. Zhang H, Forman HJ (2008) Acrolein induces heme oxygenase-1 through PKC-delta and PI3K in human bronchial epithelial cells. Am J Respir Cell Mol Biol 38, 483-490.
74. Le WD, Xie WJ, Appel SH (1999) Protective role of heme oxygenase-1 in oxidative stress-induced neuronal injury. J Neurosci Res 56, 652-658.
75. Takeda A, Perry G, Abraham NG, Dwyer BE, Kutty RK, Laitinen JT, Petersen RB, Smith MA (2000) Overexpression of heme oxygenase in neuronal cells, the possible interaction with Tau. J Biol Chem 275, 5395-5399.
76. Kanninen K, Malm TM, Jyrkkanen HK, Goldsteins G, Keksa-Goldsteine V, Tanila H, Yamamoto M, Yla-Herttuala S, Levo-nen AL, Koistinaho J (2008) Nuclear factor erythroid 2-related factor 2 protects against beta amyloid. Mol Cell Neurosci 39, 302-313.
77. Nemoto S, Finkel T (2002) Redox regulation of forkhead proteins through a p66shc-dependent signaling pathway. Science 295, 2450-2452.
78. Giorgio M, Migliaccio E, Orsini F, Paolucci D, Moroni M, Contursi C, Pelliccia G, Luzi L, Minucci S, Marcaccio M, Pinton P, Rizzuto R, Bernardi P, Paolucci F, Pelicci PG (2005) Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell 122, 221-233.
79. Holzer M, Rodel L, Seeger G, Gartner U, Narz F, Janke C, Heumann R, Arendt T (2001) Activation of mitogen-activated protein kinase cascade and phosphorylation of cytoskeletal proteins after neurone-specific activation of p21ras. II. Cy-toskeletal proteins and dendritic morphology. Neuroscience 105, 1041-1054. (Pubitemid 32786816)
80. Garver TD, Oyler GA, Harris KA, Polavarapu R, Damuni Z, Lehman RA, Billingsley ML (1995) Tau phosphorylation in brain slices: pharmacological evidence for convergent effects of protein phosphatases on tau and mitogen-activated protein kinase. Mol Pharmacol 47, 745-756.
81. Diaz-Hernandez M, Hernandez F, Martin-Aparicio E, Gomez-Ramos P, Moran MA, Castano JG, Ferrer I, Avila J, Lucas JJ (2003) Neuronal induction of the immunoproteasome in Huntington's disease. J Neurosci 23, 11653-11661.
82. Perry G, Roder H, Nunomura A, Takeda A, Friedlich AL, Zhu X, Raina AK, Holbrook N, Siedlak SL, Harris PL, Smith MA (1999) Activation of neuronal extracellular receptor kinase (ERK) in Alzheimer disease links oxidative stress to abnormal phosphorylation. Neuroreport 10, 2411-2415.
83. Ferrer I, Blanco R, Carmona M (2001) Differential expression of active, phosphorylation-dependent MAP kinases, MAPK/ERK, SAPK/JNK and p38, and specific transcription factor substrates following quinolinic acid excitotoxicity in the rat. Brain Res Mol Brain Res 94, 48-58.
84. Jang JH, Surh YJ (2005) Beta-amyloid-induced apoptosis is associated with cyclooxygenase-2 up-regulation via the mitogen-activated protein kinase-NF-kappaB signaling pathway. Free Radic Biol Med 38, 1604-1613.
85. Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA, Mayo MW (2004) Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EM-BO J 23, 2369-2380.
86. Chen J, Zhou YG, Mueller-Steiner S, Chen LF, Kwon H, Yi SL, Mucke L, Li G (2005) SIRT1 protects against microglia-dependent amyloid-beta toxicity through inhibiting NF-kappa B signaling. J Biol Chem 280, 40364-40374.
87. Kim D, Nguyen MD, Dobbin MM, Fischer A, Sananbenesi F, Rodgers JT, Delalle I, Baur JA, Sui G, Armour SM, Puigserver P, Sinclair DA, Tsai LH (2007) SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis. EMBOJ 26, 3169-3179.